Quantum BioPharma Ltd. (QNTM)

NASDAQ: QNTM · Real-Time Price · USD

5.37

+0.92 (20.67%)

At close: Apr 28, 2026, 4:00 PM EDT

5.41

+0.04 (0.74%)

After-hours: Apr 28, 2026, 7:56 PM EDT

Quantum BioPharma Employees

Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.

Employees

17

Change (1Y)

7

Growth (1Y)

70.00%

Revenue / Employee

n/a

Profits / Employee

-$1,539,723

Market Cap

26.07M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2022	17	7	70.00%
Dec 31, 2021	10	1	11.11%
Dec 31, 2020	9	-9	-50.00%
Dec 31, 2019	18	-1	-5.26%
Dec 31, 2018	19	-	-

Related Stocks

Company Name	Employees
Vistagen Therapeutics	59
Quince Therapeutics	38
OSR Holdings	22
Jasper Therapeutics	22
NewcelX	15
VYNE Therapeutics	10
Cocrystal Pharma	10
Allarity Therapeutics	8

Employee Rankings

QNTM News

1 day ago - Quantum BioPharma Provides Corporate Update - GlobeNewsWire
6 days ago - Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - GlobeNewsWire
27 days ago - Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - GlobeNewsWire
4 weeks ago - Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis - GlobeNewsWire
4 weeks ago - Quantum Biopharma Provides Corporate Update - GlobeNewsWire
4 weeks ago - Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status - GlobeNewsWire
5 weeks ago - Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd - GlobeNewsWire
5 weeks ago - Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering - GlobeNewsWire